JP2024505449A5 - - Google Patents

Info

Publication number
JP2024505449A5
JP2024505449A5 JP2023543321A JP2023543321A JP2024505449A5 JP 2024505449 A5 JP2024505449 A5 JP 2024505449A5 JP 2023543321 A JP2023543321 A JP 2023543321A JP 2023543321 A JP2023543321 A JP 2023543321A JP 2024505449 A5 JP2024505449 A5 JP 2024505449A5
Authority
JP
Japan
Prior art keywords
compound
cells
optionally substituted
lnp
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023543321A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024505449A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/012951 external-priority patent/WO2022159472A1/en
Publication of JP2024505449A publication Critical patent/JP2024505449A/ja
Publication of JP2024505449A5 publication Critical patent/JP2024505449A5/ja
Pending legal-status Critical Current

Links

JP2023543321A 2021-01-20 2022-01-19 生分解性特徴を含むナノ材料 Pending JP2024505449A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163139731P 2021-01-20 2021-01-20
US63/139,731 2021-01-20
PCT/US2022/012951 WO2022159472A1 (en) 2021-01-20 2022-01-19 Nanomaterials comprising a biodegradable feature

Publications (2)

Publication Number Publication Date
JP2024505449A JP2024505449A (ja) 2024-02-06
JP2024505449A5 true JP2024505449A5 (cg-RX-API-DMAC10.html) 2025-01-27

Family

ID=82549757

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023543321A Pending JP2024505449A (ja) 2021-01-20 2022-01-19 生分解性特徴を含むナノ材料

Country Status (10)

Country Link
US (2) US12268753B2 (cg-RX-API-DMAC10.html)
EP (1) EP4281080A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024505449A (cg-RX-API-DMAC10.html)
KR (1) KR20230135060A (cg-RX-API-DMAC10.html)
CN (1) CN116847853A (cg-RX-API-DMAC10.html)
AU (1) AU2022210316A1 (cg-RX-API-DMAC10.html)
CA (1) CA3203628A1 (cg-RX-API-DMAC10.html)
IL (1) IL303845A (cg-RX-API-DMAC10.html)
MX (1) MX2023008328A (cg-RX-API-DMAC10.html)
WO (1) WO2022159472A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7600208B2 (ja) 2019-07-29 2024-12-16 ジョージア テック リサーチ コーポレイション 拘束された脂質を含むナノ材料およびその使用
CN115175894B (zh) 2020-01-09 2024-09-06 盖德治疗有限责任公司 纳米材料
EP4281080A4 (en) 2021-01-20 2025-09-24 Beam Therapeutics Inc NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
CN116761888A (zh) 2021-01-20 2023-09-15 比姆医疗股份有限公司 纳米材料
JP7883580B2 (ja) * 2021-10-08 2026-07-01 スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド 脂質化合物及び脂質ナノ粒子組成物
EP4540222A1 (en) * 2022-07-20 2025-04-23 Beam Therapeutics Inc. Nanomaterials comprising triols
WO2024078614A1 (zh) * 2022-10-13 2024-04-18 深圳深信生物科技有限公司 用于递送生物活性成分的氨基脂质化合物和脂质纳米颗粒
EP4644377A1 (en) * 2022-12-30 2025-11-05 Nanjing Cybernax Biomedical Technology Co., Ltd. Lipid compound for gene delivery and lipid nanoparticle comprising same
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
WO2025038864A1 (en) * 2023-08-16 2025-02-20 Beam Therapeutics Inc. Ionizable lipids with linear head groups
WO2025157978A1 (en) 2024-01-26 2025-07-31 Merck Patent Gmbh Ionizable lipids for use in lipid nanoparticles
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026090423A1 (en) * 2024-10-23 2026-04-30 Prime Medicine, Inc Universal lnp compositions

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL257307A (cg-RX-API-DMAC10.html) 1959-10-28
US3686238A (en) 1970-01-19 1972-08-22 Syntex Corp Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
EP1021549A2 (en) 1997-09-19 2000-07-26 Sequitur, Inc. SENSE mRNA THERAPY
EP1164125A4 (en) 1999-11-08 2005-05-04 Daicel Chem ADAMANTANE DERIVATIVES AND PROCESS FOR PREPARING
CN100523215C (zh) 2000-12-01 2009-08-05 马普科技促进协会 介导rna干涉的小rna分子
WO2003101952A2 (en) 2002-05-31 2003-12-11 The Regents Of The University Of California Polyamine-mediated transfection
JP2005181734A (ja) 2003-12-19 2005-07-07 Fuji Photo Film Co Ltd 画像記録材料
DE102007029471A1 (de) 2007-06-20 2008-12-24 Novosom Ag Neue fakultativ kationische Sterole
EP2279254B1 (en) 2008-04-15 2017-07-05 Protiva Biotherapeutics Inc. Novel lipid formulations for nucleic acid delivery
EP4481047A3 (en) 2010-06-03 2025-04-16 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
US9512073B2 (en) 2011-10-27 2016-12-06 Massachusetts Institute Of Technology Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
DE21212055T1 (de) 2011-12-07 2022-08-04 Alnylam Pharmaceuticals, Inc. Biologisch abbaubare lipide zur freisetzung von wirkstoffen
ES2887254T3 (es) 2013-03-08 2021-12-22 Novartis Ag Lípidos y composiciones lipídicas para el suministro de agentes activos
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
US10059655B2 (en) 2013-12-19 2018-08-28 Novartis Ag Lipids and lipid compositions for the delivery of active agents
US10426737B2 (en) 2013-12-19 2019-10-01 Novartis Ag Lipids and lipid compositions for the delivery of active agents
ES2969956T3 (es) 2014-09-05 2024-05-23 Novartis Ag Lípidos y composiciones lipídicas para el suministro de agentes activos
WO2016187531A1 (en) 2015-05-21 2016-11-24 Ohio State Innovation Foundation Benzene-1,3,5-tricarboxamide derivatives and uses thereof
HRP20220156T1 (hr) 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
CN108368028B (zh) 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
ES3030658T3 (en) 2016-03-30 2025-07-01 Intellia Therapeutics Inc Lipid nanoparticle formulations for crispr/cas components
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
RS63953B1 (sr) 2017-03-15 2023-02-28 Modernatx Inc Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava
BR112019025104A2 (pt) 2017-05-30 2020-06-23 Glaxosmithkline Biologicals S.A. Método de fabricar um sistema de entrega não viral, sistema de entrega não viral, e, composição
KR102710962B1 (ko) 2017-07-04 2024-09-27 주식회사 인투셀 절단성 링커를 포함하는 화합물 및 이들의 용도
JP7449231B2 (ja) 2017-10-30 2024-03-13 ジョージア テック リサーチ コーポレーション 組織送達用材料の多重化解析
US11622942B2 (en) 2017-11-14 2023-04-11 Ohio State Innovation Foundation Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereof
EP3727362A4 (en) 2017-12-19 2021-10-06 PureTech LYT, Inc. MYCOPHENOLIC ACID LIPID PRODRUGS AND THEIR USES
CN111542338B (zh) 2017-12-27 2024-06-18 武田药品工业株式会社 含核酸脂质纳米粒子及其用途
CN112955099B (zh) 2018-07-27 2024-04-26 雷森斯医疗有限公司 医疗冷却装置和使用其的冷却方法
US20210300962A1 (en) 2018-08-02 2021-09-30 Puretech Lyt, Inc. Lipid prodrugs of pregnane neurosteroids and uses thereof
JP7436990B2 (ja) 2018-08-10 2024-02-22 国立大学法人京都大学 カチオン性脂質を用いた心筋細胞へのトランスフェクション方法
MX2021003455A (es) * 2018-10-02 2021-09-21 Intellia Therapeutics Inc Lípidos con amina ionizables.
CN119285480A (zh) 2018-12-05 2025-01-10 英特利亚治疗股份有限公司 改性的胺脂质
EP3911302B1 (en) 2019-01-17 2025-09-10 Georgia Tech Research Corporation Drug delivery systems containing oxidized cholesterols
ES3025233T3 (en) 2019-01-24 2025-06-06 Agfa Nv Radiation curable inkjet inks for interior decoration
EP3924479A4 (en) 2019-02-13 2023-01-25 Beam Therapeutics, Inc. ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING THEM TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE
WO2020176868A1 (en) 2019-02-28 2020-09-03 Puretech Lyt, Inc. Lipid prodrugs of btk inhibitors and uses thereof
WO2020176856A1 (en) 2019-02-28 2020-09-03 Puretech Lyt, Inc. Lipid prodrugs of glucocorticoids and uses thereof
AU2020228662A1 (en) 2019-02-28 2021-09-09 Monash University Lipid prodrugs of JAK inhibitors and uses thereof
WO2020219876A1 (en) * 2019-04-25 2020-10-29 Intellia Therapeutics, Inc. Ionizable amine lipids and lipid nanoparticles
US20220233459A1 (en) 2019-06-05 2022-07-28 Guide Therapeutics, Inc. Analysis of materials for tissue delivery
CA3143865A1 (en) 2019-06-07 2020-12-10 Fujifilm Corporation Lipid composition
EP4004207A4 (en) 2019-07-29 2023-08-23 Georgia Tech Research Corporation OLIGONUCLEOTIDE ANTAGONISTS FOR RNA-GUIDED GENO EDITING
JP7600208B2 (ja) 2019-07-29 2024-12-16 ジョージア テック リサーチ コーポレイション 拘束された脂質を含むナノ材料およびその使用
JP2022552724A (ja) 2019-10-21 2022-12-19 フラスクワークス, エルエルシー 細胞培養のためのシステムおよび方法
JP7699128B2 (ja) 2019-12-06 2025-06-26 ガイド セラピューティクス,エルエルシー ナノマテリアル
CN115175894B (zh) * 2020-01-09 2024-09-06 盖德治疗有限责任公司 纳米材料
WO2022060871A1 (en) * 2020-09-15 2022-03-24 Verve Therapeutics, Inc. Lipid formulations for gene editing
JP2024508347A (ja) 2020-12-21 2024-02-27 ビーム セラピューティクス インク. エステル結合アセタールを含むナノ材料
EP4262817A4 (en) 2020-12-21 2025-03-12 Beam Therapeutics Inc. NANOMATERIALS WITH ACETALS
JP2024505327A (ja) 2020-12-21 2024-02-06 ビーム セラピューティクス インク. 炭酸塩を含むナノ材料
CN116761888A (zh) 2021-01-20 2023-09-15 比姆医疗股份有限公司 纳米材料
CA3203741A1 (en) 2021-01-20 2022-07-28 Beam Therapeutics Inc. Nanomaterials comprising an ionizable lipid
EP4281080A4 (en) 2021-01-20 2025-09-24 Beam Therapeutics Inc NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
AU2022210299A1 (en) 2021-01-20 2023-06-29 Beam Therapeutics Inc. Ionizable lipids for nanomaterials
JP7883580B2 (ja) * 2021-10-08 2026-07-01 スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド 脂質化合物及び脂質ナノ粒子組成物
WO2023121971A1 (en) 2021-12-20 2023-06-29 Beam Therapeutics Inc. Nanomaterials comprising tetravalent lipid compounds
WO2023121965A1 (en) 2021-12-20 2023-06-29 Beam Therapeutics Inc. Nanomaterial comprising diamines
WO2023121970A1 (en) 2021-12-20 2023-06-29 Beam Therapeutics Inc. Ionizable amine and ester lipids and lipid nanoparticles
CA3241488A1 (en) 2021-12-20 2023-06-29 Beam Therapeutics Inc. Ionizable amine lipids and lipid nanoparticles
WO2023121964A1 (en) 2021-12-20 2023-06-29 Beam Therapeutics Inc. Nanomaterials comprising disulfides
EP4540222A1 (en) 2022-07-20 2025-04-23 Beam Therapeutics Inc. Nanomaterials comprising triols

Similar Documents

Publication Publication Date Title
JP2024503441A5 (cg-RX-API-DMAC10.html)
JP2024502948A5 (cg-RX-API-DMAC10.html)
JP2024502954A5 (cg-RX-API-DMAC10.html)
JP2024508347A5 (cg-RX-API-DMAC10.html)
JP2025501731A5 (cg-RX-API-DMAC10.html)
JP2025500824A5 (cg-RX-API-DMAC10.html)
CN115175894B (zh) 纳米材料
JP2024505327A (ja) 炭酸塩を含むナノ材料
CN120423969A (zh) 用于治疗剂的细胞内递送的支链尾端脂质化合物和组合物
CN112805294A (zh) 用于核酸递送的叔氨基脂化的阳离子肽
JP2022536495A5 (cg-RX-API-DMAC10.html)
JP2024540101A5 (cg-RX-API-DMAC10.html)
EP4644379A1 (en) Lipid compound and lipid nanoparticle composition
AU2003255468B2 (en) Prophylaxis and treatment of infectious diseases
Mancino et al. RNA therapies for musculoskeletal conditions
TWI876778B (zh) 用於傳遞核酸的基於環烷的脂質化合物以及包括其之脂質奈米粒子
Gao et al. Engineering a spleen-selective mRNA-LNPs vaccine by decoupling the inflammation from cellular immunity-mediated cancer immunotherapy
US20260085081A1 (en) Phosphatidylamine compounds including a plurality of tertiary amino group structures and compositions thereof
CN1845746A (zh) 单独包含去纤苷酸或与其它抗肿瘤剂联合的抗肿瘤制剂
CN117959315B (zh) 化合物pgg作为krasg12d抑制剂mrt1133的增效剂联合治疗胰腺癌的应用
JP7842738B2 (ja) バイオインスパイアード脂質誘導体及びその使用
FR3110836A1 (fr) Utilisation de NMN pour réduire l’immunodépression et l’immunosénescence
KR20240167649A (ko) 아미노 지질 화합물, 이의 제조 방법, 이의 조성물 및 이의 용도
JP6469727B2 (ja) 線維症の抑制又は治療方法
Li et al. Arginine Polymerization Boosts Anti‐Inflammatory Effects and DNA Nanostructure‐Assisted siRNA Delivery in Acute Respiratory Distress Syndrome